Skip to content

Study · Not a test of the peptide alone · 2006

1 result

Production of lymphocyte-activating factors by mouse macrophages during aging and under the effect of short peptides.

Gumen AV, Kozinets IA, Shanin SN, Malinin VV, Rybakina EG

Bulletin of experimental biology and medicine1 Sept 2006Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Epitalon.

  1. 01LabNot a test of Epitalon aloneEx vivo tissueMechanism

    In mouse peritoneal macrophages from young and old mice, short synthetic peptides including Epithalon had opposite modulating effects on production of lymphocyte-activating factors by resident and lipopolysaccharide-stimulated macrophages.

    In plain wordsIn lab tests on mouse immune cells, short peptides including Epithalon changed immune factor production in opposite directions in resident and stimulated cells.

    Peptide
    Epitalon
    Outcome
    MixedLymphocyte-activating factor production by macrophages
    Study

    mousen: not reported in source

    Peritoneal macrophages from young and old mice
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The opposite modulating effects of short peptides on the production of lymphocyte-activating factors by resident and lipopolysaccharide-stimulated macrophages in young and old mice were demonstrated for the first time.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 4 to 10Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 7 times, first on 21 Oct 2026, 17:05 UTC. The status did not change between them.

    Study results updated

  2. Version 3

    21 Oct 2026, 16:35 UTC

    Study data updated · source update from Europe PMC

  3. Version 2

    9 Oct 2026, 18:17 UTC

    Study results updated

  4. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.